Clinical Trials Directory

Trials / Completed

CompletedNCT03872635

Effects of Anesthesia on Tumor Immunity and Insulin Resistance During Perioperative Period

Effects of Drug or Drink Intervention and Temperature Protectionon for Cervical Cancer Patients on Insulin Resistance and Tumor Immunity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Fujian Cancer Hospital · Other Government
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effects of preoperative oral carbohydrate on postoperative insulin resistance and tumor immunity in cervical cancer patients with neoadjuvant chemotherapy.

Detailed description

Fifty-one patients undergoing neoadjuvant chemotherapy and radical hysterectomy with bilateral pelvic lymph node dissection were randomized to receive 300mL of an oral carbohydrate liquid supplement 2 hour before surgery(CHO group) or to fast on standard hospital protocol (8 hour fasting for solid and 4 hour fasting for clear liquid)(FAST group).According to inclusion and exclusion standards, twenty-six patients undergoing the same surgery and standard fasting were selected as control group. Baseline and postoperative measurements of insulin sensitivity were assessed in term of fasting plasma glucose(FPG),fastingainsulin(FINS),HOMA-insulinaresistance(HOMA-IR),HOMA-insulin secretion function index(HOMA-IX) , HOMA-beta cell function index(HOMA-β),serum C-peptide and glucagon.Baseline and postoperative measurements of tumor immunity were evaluated using NK cell and T-cell dynamics.VAS score was introduced to assess preoperative comfort.

Conditions

Interventions

TypeNameDescription
OTHERoral carbohydrate liquidpatients undergoing neoadjuvant chemotherapy and radical hysterectomy with bilateral pelvic lymph node dissection were randomized to receive 300mL of an oral carbohydrate liquid supplement 2 hour before surgery

Timeline

Start date
2018-01-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2019-03-13
Last updated
2019-03-13

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03872635. Inclusion in this directory is not an endorsement.